AbbVie will acquire Gilgamesh’s experimental antidepressant bretisilocin for up to $1.2 billion, aiming to bolster its ...

Lundbeck’s bexicaserin, acquired via the $2.6 billion Longboard deal, demonstrated ~59% median reduction in motor seizures ...

Overview of Surgical Sutures MarketThe global Surgical Sutures Market is valued at USD 5.66 Billion in 2024 and is projected ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Bioz, Inc., a cutting-edge AI platform that transforms research citations into powerful marketing and sales resources for companies that ...

Imperial College London Diabetes & Endocrine Centre unveils updated brand identity to reflect a fuller spectrum of endocrine careThe rebrand reinforces the centre’s position as the region’s largest ...

First chemotherapy-free trial combining ANKTIVA, an IL-15 agonist, natural killer (NK) cell therapy, and Optune ...

The lab will run the inaugural study for Project Mosaic, a groundbreaking initiative to develop patient-specific models of ...

Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of RA, a bioelectronic ...

Three-year term intended to advance preclinical development of ReSonanceUp to $12 million of development costs to be ...

Charles River Laboratories International, Inc. (NYSE: CRL) has joined the EASYGEN (Easy Workflow Integration for Gene Therapy ...

Company announces acquisition of Aster Insights, a move that creates a first-of-its-kind enterprise aimed at accelerating the ...

Chrislaina Anderson is proudly announced as the winner of the 2025 Adam Ferrari Health Science Scholarship, a $20K award ...